Health ❯ Healthcare ❯ Oncology

Blood Cancers

Leukemia Multiple Myeloma Myeloma Treatments T Cell Acute Lymphoblastic Leukemia Blastic Plasmacytoid Dendritic Cell Neoplasm Lymphoma Multiple Myeloma Relapse Aggressive Cancers B Cell Lymphoma Myeloproliferative Neoplasms Chronic Graft-Versus-Host Disease Acute Myeloid Leukemia CAR T-cell Therapy Plasma Cell Disorders

UC Irvine Proposes Mitochondrial‑Targeted, Steroid‑Sparing Strategy for CAR T Neurotoxicity

Targeting mitochondrial dysfunction offers a steroid‑sparing route that could speed clinical testing of existing drugs.

Germline Genetic Variants Shape Safety and Activity of CAR‑T Therapy

CRISPR CD33-Deleted Stem Cell Transplant Shows Early Promise for AML and MDS

Lilly to Acquire Ajax Therapeutics in Up to $2.3 Billion Blood Cancer Deal

Pivekimab Sunirine Shows 85% Response Rate in BPDCN Trial

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors